Log in
Pharmacology · Agents Used in Psychiatry and Neurology

Amitriptyline

*Amitriptylinum*

Amitriptyline (Amitriptylinum) is one of the most effective antidepressants, combining a potent thymoleptic action with a pronounced sedative effect. The drug is widely used in psychiatric and somatic practice for the treatment of depression and chronic pain syndromes.

Pharm ProfileAntidepressant with pronounced sedation
MechanismBlockade of neurotransmitter reuptake
EffectDevelops within 2–3 weeks of administration
Side EffectsAtropine-like effects and hypotension
2 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Pharmacological profile and mechanism of action

The drug is recognized as one of the most effective in its group. Its action is based on a combination of strong antidepressant properties with a pronounced sedative effect. Additionally, amitriptyline exhibits marked anticholinergic activity and antihistamine properties.

The primary mechanism consists in blocking the neuronal reuptake of norepinephrine and serotonin. Furthermore, the drug blocks presynaptic M-cholinergic receptors on adrenergic nerve terminals. This enhances the release of norepinephrine, which theoretically potentiates the overall antidepressant result. A clinically significant thymoleptic effect does not manifest immediately, but after 2–3 weeks of regular use.

Spectrum of action and indications

The spectrum of activity of amitriptyline includes several key components:

  • Elimination of anxiety and agitation (psychomotor excitation).
  • Thymoleptic action proper.
  • Pronounced analgesic activity.

In medical practice, the drug is prescribed according to two main profiles:

  1. Psychiatric: endogenous depression, anxiety-depressive and neurotic conditions.
  2. Somatic: chronic pain syndromes managed thanks to its intrinsic analgesic activity.
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Pharmacokinetics

The pharmacokinetic properties of amitriptyline ensure its systemic action in the body:

  • Absorption: characterized by good absorption upon oral administration.
  • Distribution: a high degree of plasma and tissue protein binding is observed (exceeding 90%).
  • Metabolism: biotransformation takes place in the liver.
  • Elimination: carried out predominantly by the kidneys in the form of metabolites.
  • Half-life ($T_{1/2}$): ranges from 10 to 26 hours.

Safety profile and adverse effects

Most adverse reactions are related to the non-selectivity of the drug's action and its effect on off-target receptor systems:

  • Atropine-like effects (blockade of peripheral M-cholinergic receptors): xerostomia (dry mouth), mydriasis, impaired accommodation, and urinary retention.
  • Vascular effects: blockade of $\alpha$-adrenergic receptors leads to orthostatic hypotension and cardiac arrhythmias.
  • CNS and others: somnolence, dizziness, and allergic reactions are possible.

Briefly: answers to topical questions

What are the absolute contraindications to the use of amitriptyline?

Absolute contraindications to the use of amitriptyline include:

  • Heart diseases.
  • Glaucoma.
  • Prostatic hyperplasia.
  • Chronic constipation.
  • Pediatric age under 18 years.

What symptoms are characteristic of acute amitriptyline overdose?

Acute amitriptyline overdose is characterized by symptoms associated with its M-cholinergic blocking activity, wherein coma is preceded by a period of agitation and sometimes seizures.

In the coma stage, the clinical picture includes:

  • Cardiac disorders — tachycardia, atrial fibrillation, atrioventricular or intraventricular block.
  • Psychotic episodes — development of delirium-like hallucinations.
  • Autonomic disorders — intestinal and bladder atony.

Class and exam questions

What mechanism underlies the antidepressant action of amitriptyline?

The drug blocks the reuptake of neurotransmitters such as norepinephrine and serotonin. Additionally, it blocks presynaptic M-cholinergic receptors on adrenergic terminals, enhancing the release of norepinephrine.

After what time does the clinically significant effect develop?

A clinically significant antidepressant effect does not occur immediately, but upon systematic administration of the drug after 2–3 weeks.

What are the main side effects of amitriptyline associated with?

Side reactions are caused by the non-selectivity of the drug's action, in particular the blockade of peripheral M-cholinergic receptors (dry mouth, urinary retention) and $\alpha$-adrenergic receptors (orthostatic hypotension).

Something unclear? Ask the AIThe AI tutor has read the material on "Amitriptyline" and will explain it in simple terms.

What else to study on this topic

  • Features of presynaptic M-cholinergic receptor blockade
  • The relationship between analgesic activity and the treatment of chronic pain
  • Causes of orthostatic hypotension during alpha-adrenergic receptor blockade
  • The time lag of the antidepressant action and its pharmacodynamic rationale
  • Differences between psychiatric and somatic application profiles

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Amitriptyline" and another 5,304 pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Agents Used in Psychiatry and Neurology"

The entire section "Agents Used in Psychiatry and Neurology"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.